Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLESENCE, INC. Director's Dealing 2006

Oct 27, 2006

33563_dirs_2006-10-27_919bacf8-3f05-46ce-873b-47d6aa0b64d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2006-10-26

Reporting Person: BROTZMAN RICHARD W (VP - Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-10-26 Common Stock M 13420 $3.8125 Acquired 13420 Direct
2006-10-26 Common Stock S 5920 $6.72 Disposed 7500 Direct
2006-10-26 Common Stock S 2500 $6.7329 Disposed 5000 Direct
2006-10-26 Common Stock S 2500 $6.7347 Disposed 2500 Direct
2006-10-26 Common Stock S 2500 $6.73 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-10-26 Common Stock (right to buy) $3.8125 M 13420 Disposed 2008-07-31 Common Stock (40600) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Common Stock (right to buy) $7.6875 2010-05-24 Common Stock (22500) 22500 Direct
Common Stock (right to buy) $10.875 2011-01-26 Common Stock (20000) 20000 Direct
Common Stock (right to buy) $7.0625 2011-02-28 Common Stock (20000) 20000 Direct
Common Stock (right to buy) $6.65 2012-01-03 Common Stock (20000) 20000 Direct
Common Stock (right to buy) $3.66 2013-03-24 Common Stock (20000) 20000 Direct
Common Stock (right to buy) $5.55 2014-10-11 Common Stock (11000) 11000 Direct
Common Stock (right to buy) $6.03 2015-09-27 Common Stock (10000) 10000 Direct
Common Stock (right to buy) $6.01 2016-09-27 Common Stock (15000) 15000 Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in five equal installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.